Abstract. Vascular endothelial growth factor (VEGF) is a well known angiogenic factor that has been suggested to play some physiological roles in reproductive organs. To clarify whether VEGF is involved in regulating bovine endometrial function locally, in experiment 1, we determined the expression of VEGF, VEGF receptor (VEGFR) 1 and VEGFR2 throughout the estrous cycle in endometrial tissues. Endometrial tissue was collected at estrus (Day 0), the early I (Days 2-3), early II (Days 5-6), mid and late luteal stages and the follicular stage . RT-PCR and Western blotting analysis revealed that VEGF mRNA expression at estrus was higher than at the early I, early II and late luteal stages (P<0.05), whereas VEGF protein content was greatest at the early I luteal stage and decreased thereafter. VEGFR1 mRNA expression was lower at estrus and at the early I and early II luteal stages than at the other stages, whereas VEGFR1 protein expression did not change significantly throughout the estrous cycle (P<0.05). VEGFR2 mRNA expression was higher at the mid and late luteal stages than at the early I and early II luteal stages, and VEGFR2 protein was higher at the mid and late luteal stages than at estrus (P<0.05). In experiment 2, to determine the effect of VEGF on prostaglandin (PG) F2α and PGE2 production by endometrial cells, cultured endometrial epithelial and stromal cells were exposed to VEGF (0, 5, 50, 100 and 200 ng/ml) for 24 h. VEGF (200 ng/ml) stimulated PGF2α production by stromal cells (P<0.05), but not PGE2 production. VEGF did not affect PG production by endometrial epithelial cells. The overall results suggest that VEGF and its receptors are regulated throughout the estrous cycle and that VEGF participates in the local regulation of bovine endometrial function by a selective modulation of PGF2α production in stromal cells in an auto-and/or paracrine manner. Key words: Bovine, Endometrium, Estrous cycle, VEGF, VEGF receptors (J. Reprod. Dev. 56: [223][224][225][226][227][228][229] 2010) ascular endothelial growth factor (VEGF) is a well known angiogenic factor that plays important physiological roles in a wide range of cells and tissues [1] . In reproductive organs, VEGF is required for normal ovarian angiogenesis and growth of the endometrium throughout the ovulatory cycle in humans [2, 3] and rodents [4, 5] . In addition, the vascular hyperpermeability induced by VEGF seems to be essential for normal implantation in rodents [6] . The above findings suggest that VEGF has pivotal roles in regulating the functions of the cyclic and pregnant endometrium. In cows, VEGF expression has been observed in the ovary [7, 8] The biological actions of VEGF are mediated by two types of tyrosine kinase receptors, VEGFR1 (Flt-1) and VEGFR2 (Flk-1/ KDR) [1, 11] . VEGFR1 has a high affinity for VEGF, and its signal for angiogenesis is weak [12] . Although VEGFR1 mediates an essential signal for normal vascularization, it seems that VEGFR1 does not mediate stimulation of endothelial cell proliferation [13] . The exact function of VEGF mediated by VEGFR1 in the endometrium remains unclear. VEGFR2 is known as a major positive signal transducer for angiogenesis [11] . It has been reported that VEGFR2 knockout mice die due to a lack of angiogenesis [14] . The strong tyrosine kinase activity of VEGFR2 has been suggested to be one of the major signals for angiogenesis [11, 12, 14, 15] . However, the expression of VEGFR1 and VEGFR2 during the estrous cycle in the bovine endometrium has not been clarified.
(J. Reprod. Dev. 56: 223-229, 2010) ascular endothelial growth factor (VEGF) is a well known angiogenic factor that plays important physiological roles in a wide range of cells and tissues [1] . In reproductive organs, VEGF is required for normal ovarian angiogenesis and growth of the endometrium throughout the ovulatory cycle in humans [2, 3] and rodents [4, 5] . In addition, the vascular hyperpermeability induced by VEGF seems to be essential for normal implantation in rodents [6] . The above findings suggest that VEGF has pivotal roles in regulating the functions of the cyclic and pregnant endometrium. In cows, VEGF expression has been observed in the ovary [7, 8] and oviducts [9] throughout the estrous cycle and in the corpus luteum [8] , placenta [10] and endometrium [10] during pregnancy. However, the expressions and functions of VEGF in the bovine endometrium during the estrous cycle have not yet been clarified.
The biological actions of VEGF are mediated by two types of tyrosine kinase receptors, VEGFR1 (Flt-1) and VEGFR2 (Flk-1/ KDR) [1, 11] . VEGFR1 has a high affinity for VEGF, and its signal for angiogenesis is weak [12] . Although VEGFR1 mediates an essential signal for normal vascularization, it seems that VEGFR1 does not mediate stimulation of endothelial cell proliferation [13] . The exact function of VEGF mediated by VEGFR1 in the endometrium remains unclear. VEGFR2 is known as a major positive signal transducer for angiogenesis [11] . It has been reported that VEGFR2 knockout mice die due to a lack of angiogenesis [14] . The strong tyrosine kinase activity of VEGFR2 has been suggested to be one of the major signals for angiogenesis [11, 12, 14, 15] . However, the expression of VEGFR1 and VEGFR2 during the estrous cycle in the bovine endometrium has not been clarified.
In addition to its angiogenic action, VEGF has been shown to stimulate prostaglandin (PG) E2 and PGF2α biosynthesis in the bovine oviduct, facilitating the transport of the embryo into the uterus [16] . PGs are bioactive lipids produced from membranes rich in arachidonic acid [17] . Arachidonic acid is transformed by specific enzymes including cyclooxygenase (COX) and two PG synthases [17] . In cows, pulsatile release of PGF2α from the uterus is known to induce luteolysis [18, 19] , whereas PGE2 has been suggested to be a temporary luteoprotective factor [20, 21] . Oxytocin and tumor necrosis factor-α are well-known positive stimulators of PGF2α production in the bovine endometrium [19] , although the detailed regulatory mechanism of PG production in the bovine endometrium has not yet been clarified. Thus, we examined whether VEGF is one of the regulators of endometrial PG production throughout the estrous cycle.
The aim of the present study was to clarify whether VEGF is involved in the local regulation of bovine endometrial function. We investigated 1) the mRNA and protein expression of VEGF and its receptors in the bovine endometrium throughout the estrous cycle and 2) the effects of VEGF on PGF2α and PGE2 production by bovine endometrial epithelial and stromal cells in vitro.
Materials and Methods

Collection of endometrial tissues
Uteri of Holstein cows were obtained at a local abattoir within 10-20 min after exsanguination in accordance with protocols approved by the local institutional animal care and use committee. Apparently healthy uteri without a visible conceptus were immediately transported to the laboratory on ice. The stages of the estrous cycle were determined based on macroscopic observation of the ovary (corpus luteum and follicles) and uterine characteristics (size, color, tonus consistency, mucus, etc.). Other details have been described in our previous study [22] . Only endometrial samples from cows that clearly fulfilled the criteria described for each stage were used in the present study. . Intercaruncular endometrial tissues from the uterine horn, ipsilateral to the CL, were stripped from the uterus by using forceps and a razor (5 mm × 20 mm, 5-10 pieces from each uterus). The tissues were then immediately frozen in liquid nitrogen and stored at -80 C until processed for RNA and protein isolation.
Isolation and culture of endometrial cells
For cell culture, endometrial tissues were obtained at the early luteal stage (Days 2-5). The epithelial and stromal cells from the bovine endometrium were separated as described previously [23] . A polyvinyl catheter was inserted into the side of the oviduct, and the ends of the horn were tied in order to retain trypsin solution for detaching the epithelial cells as described below. Epithelial cells were isolated by incubation at 38 C for 60 min with gentle shaking. After collection of the epithelial cells, the horn was then cut transversely with scissors into several segments. Intercaruncular endometrial strips were dissected from the myometrial layer with a scalpel. The endometrial strips were then minced into small pieces (1 mm 3 ). The minced tissues (approximately 5 g) were digested by stirring for 60 min in 50 ml of sterile HBSS containing 0.05% (w/v) collagenase (Sigma, St. Louis, MO, USA; C0130), 0.005% (w/v) deoxyribonuclease I (Sigma; D5025) and 0.1% BSA (Roche, Manheim, Germany; 10735078001). The dissociated cells were filtered through metal meshes (100 μm and 80 μm) to remove undissociated tissue fragments. The filtrate was washed 3 times by centrifugation (100 × g for 10 min at 4 C) with Dulbecco's Modified Eagle's Medium (DMEM; Sigma; D1152) supplemented with antibiotics and 0.1% BSA. After the washes, the cells were counted with a hemocytometer. Cell viability was higher than 85% as assessed by 0.5% (w/v) trypan blue dye exclusion.
The final pellets of the stromal and epithelial cells were separately resuspended in culture medium (DMEM/Ham's F-12; 1:1 (v/ v); Sigma; D8900) supplemented with 10% (v/v) calf serum (Sigma; C6278), 20 μg/ml gentamicin (Invitrogen; 15750-060) and 2 μg/ml amphotericin B (Sigma; A9528). Cell viability was higher than 80% as assessed by trypan blue dye exclusion. These cells were seeded at a density of 1 × 10 5 viable cells/ml, 0.5 × 10 5 viable cells per culture dish well (Greiner Bio-One, Frickenhausen, Germany; 677180) and 6 × 10 5 viable cells per culture flask (Nunc; 136196) and cultured at 38 C in a humidified atmosphere of 5% CO2 in air. To purify the stromal preparation, the medium was changed 2 h after plating, by which time selective attachment of stromal cells had occurred [24] . Alternatively, since the epithelial cells attached 24-48 h after plating, the medium in the epithelial cell culture was replaced 48 h after plating. The medium was changed every 2 days until the cells reached confluence. When the epithelial cells were confluent, 0.02% trypsin (Sigma; T4799) solution was added to the cells to remove the stromal cells and then 0.25% trypsin (Sigma; T4665) solution was added to the cells to collect the pure epithelial cells. The cells were placed in fresh DMEM/Ham's F-12 supplemented with 10% calf serum, 20 μg/ml gentamicin and 2 μg/ml amphotericin B to adjust them to a density of 1 × 10 5 viable cells/ml. These cells were seeded at a density of 1 × 10 5 viable cells/ml and 0.5 × 10 5 viable cells per culture dish well and cultured at 38C in a humidified atmosphere of 5% CO2 in air until the cells reached confluence. When cells of each type were confluent (6-7 days after the start of the culture), the cells were used for the experiments. The homogeneity of stromal cells and epithelial cells was evaluated using immunofluorescent staining for specific markers of epithelial (cytokeratin) and stromal cells (vimentin) as described previously [25, 26] . The epithelial cell contamination of stromal cells was about 1%, and the stromal cells contamination of epithelial cells was <1%. These values were similar to the results of our previous study [25, 27] . The medium was replaced with fresh DMEM/Ham's F-12 supplemented with 0.1% BSA, 5 ng/ml sodium selenite (Sigma; S5261), 0.5 mM ascorbic acid (Wako Pure Chemical Industries, Osaka, Japan; 013-12061), 5 μg/ml transferrin (Sigma; T3400), 2 μg/ml insulin (Sigma; I-4011) and 20 μg/ml gentamicin. The cells were then exposed to VEGF in the Experiment 2.
Experiment 1. VEGF, VEGFR1 and VEGFR2 mRNA and protein expression throughout the estrous cycle
Reverse Transcription and Real-time PCR: Total RNA was extracted from endometrial tissue and cells using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA; 15596-026) according to the manufacturer's directions. One μg of each total RNA was reverse transcribed using a ThermoScript TM RT-PCR System (Invitrogen; 11146-016), and 10% of the reaction mixture was used in each PCR using specific primers for VEGF 165, VEGFR1 and VEGFR2 from the bovine sequence [28] (See Table 1 ). Quantification of mRNA expression was determined using a QuantiTect TM SYBR Green PCR system (Qiagen GmbH, Hilden, Germany) starting with 2 ng of reverse-transcribed total RNA as described previously [29] .
Briefly, GAPDH expression was used as an internal control. For quantification of the mRNA expression levels [27] , PCR was performed under the following conditions: 95 C for 15 min, and then 55 cycles of 94 C for 15 sec, 55 C for 20 sec and 72 C for 15 sec. Use of the QuantiTect TM SYBR Green PCR system at elevated temperatures resulted in reliable and sensitive quantification of the RT-PCR products with high linearity (Pearson correlation coefficient: r>0.99).
Western blotting analysis: VEGF, VEGFR1 and VEGFR2 proteins in the bovine endometrial tissues were detected by Western blotting analysis. Endometrial tissues for Western blotting were homogenized on ice in homogenization buffer by a tissue homogenizer (Physcotron; NITI-ON, Chiba, Japan; NS-50) and then filtered with a metal wire mesh (150 μm). For protein analysis, nuclei were removed from the tissue homogenates by centrifugation (100 × g) for 10 min at 4 C. The resultant supernatant, which contained the cytosol and membrane fractions, was used for VEGF, VEGFR1 and VEGFR2 protein analysis. The protein concentrations of the lysates were determined by the method of Osnes et al. [30] RPN2109). β-actin protein expression was used as an internal control. The intensity of the immunological reaction in the tissues was estimated by measuring the optical density in the defined area by computerized densitometry using NIH Image (National Institutes of Health).
Experiment 2. Effect of VEGF on PGF2α and PGE2 production by epithelial and stromal cells
Endometrial epithelial and stromal cells were exposed to VEGF (ProSpec-Tany TechnoGene, Rehovot, Israel; CYY-339, 0, 5, 50, 100 and 200 ng/ml) and cultured for 6 or 24 h. After culture, the conditioned media were collected in 1.5-ml tubes containing 5 μl of a stabilizer solution (0.3 M EDTA, 1% (W/V) acid acetyl salicylic pH 7.3) and frozen at -30 C until PG assay. The concentrations of PGF2α and PGE2 in the culture medium were determined by enzyme immunoassay (EIA) as described previously [31] . The PGF2α standard curve ranged from 0.016-4 ng/ml, and the ED-50 of the assay was 0.25 ng/ml. The PGE2 standard curve ranged from 0.039-10 ng/ml, and the ED-50 of the assay was 0.625 ng/ml. The DNA content, estimated by the spectrophotometric method of Labarca and Paigen (1980) , was used to standardize the results [32] .
Statistical analysis
The experimental data are shown as the means ± SEM of values obtained from 4-5 endometria/stage. The statistical significance of differences in mRNA and protein expression, and PG productions were assessed by analysis of variance (ANOVA) followed by a Fisher protected least-significant difference procedure (PLSD) as a multiple comparison test using computer software (SAS Institute, Cary, NC, USA; StatView).
Results
Experiment 1. VEGF, VEGFR1, VEGFR2 mRNA and protein expression throughout the estrous cycle
VEGF mRNA and protein expressions in the bovine endometrium throughout the estrous cycle: VEGF mRNA and pro- tein were expressed in the bovine endometrium throughout the estrous cycle (Fig. 1) . VEGF mRNA expression at estrus was significantly higher than at the early I, early II and late luteal stages (Fig. 1a: P<0.05) . The greatest VEGF protein expression was detected at the early I luteal stage and decreased thereafter (Fig. 1b: P<0.05).
VEGFR 1 mRNA and protein expression in the bovine endometrium throughout the estrous cycle: VEGFR1 mRNA and protein were expressed in the bovine endometrium throughout the estrous cycle (Fig. 2) . VEGFR1 mRNA expression was lower at estrus, the early I and early II luteal stages than at the other stages (Fig. 2a: P<0.05) , whereas VEGFR1 protein expression did not change significantly throughout the estrous cycle (Fig. 2b) . VEGFR 2 mRNA and protein expression in the bovine endometrium throughout the estrous cycle: VEGFR2 mRNA and protein were expressed in the bovine endometrium throughout the estrous cycle (Fig. 3) . VEGFR2 mRNA expression was higher at the mid and late luteal stages than at the early I and early II luteal stages (Fig. 3a: P<0.05). VEGFR2 protein was higher at the mid and late luteal stages than at estrus (Fig. 3b: P<0.05) . Furthermore, VEGFR2 protein was higher at the mid luteal stage than at the early I luteal stage.
Experiment 2. Effect of VEGF on PGE2 and PGF2α production
In bovine endometrial stromal cells, VEGF (200 ng/ml) stimu- lated PGF2α production only in cells cultured for 24 h (Fig. 4a) .
On the other hand, VEGF did not affect PGE2 production in stromal cells (Fig. 4b) . In endometrial epithelial cells, VEGF affected neither PGF2α nor PGE2 production of cells cultured for 24 h (Fig.  5) .
Discussion
The present study demonstrated, for the first time, the detailed expression of VEGF, VEGFR1 and VEGFR2 protein and mRNA in the bovine endometrium at different stages of the estrous cycle.
The expression of VEGF mRNA was greatest at estrus, and the expression of protein was highest at the early I luteal stage. Estradiol-17β (E2) regulates VEGF mRNA expression in human endometrial cells [33] and the rat uterus [5, 6, 34] . In cows, E2 secretion is highest at estrus [21] . Thus, the greatest expression of VEGF mRNA expression at estrus may be stimulated by E2. The proliferation and differentiation of endometrial epithelial and stromal cells are controlled by E2 and progesterone [35, 36] , and E2 affects epithelial proliferation indirectly via several paracrine factors including growth factors [35] . In the marmoset, VEGF has been reported to stimulate not only angiogenesis but also proliferation of endometrial epithelial and stromal cells [37] . The above findings suggest that the VEGF mRNA and protein expressions observed in the present study are induced by E2 and that VEGF plays a role in endometrial growth at estrus and the early I luteal stage in cattle. However, it remains unclear whether the high VEGF expression detected at the early luteal stage indicates high activity of VEGF.
VEGFR1 mRNA expression increased between the mid luteal stage and the follicular stage, whereas VEGFR1 protein expression did not change significantly throughout the estrous cycle. The unchanged VEGFR1 protein expression during the estrous cycle suggests that VEGF function mediated by VEGFR1 plays a constant role in the bovine endometrium during the estrous cycle. In the mammalian uterus, angiogenesis and degeneration of blood vessels occur throughout the estrous cycle [38] . VEGFR1 has been suggested to be essential for the organization of vasculature, but not to be essential for endothelial cell proliferation in the mouse [14] . In the above study, abnormal proliferation of endothelial cells and subsequent embryo death were observed in the VEGFR1 mutant mouse embryo [13] . The constant expression of VEGFR1 protein may be related to normal vascularization rather than endothelial cell proliferation in the bovine endometrium. However, since detailed information on angiogenesis in the bovine endometrium throughout the estrous cycle is not yet available, further studies are needed to reveal whether the angiogenic role of VEGF is mediated by VEGFR1 in the bovine endometrium throughout the estrous cycle. In the present study, VEGFR2 mRNA expression was higher at the mid and late luteal stages than at the early II luteal stage. VEGFR2 protein expression was higher at the mid and late luteal stages than at estrus. It has been reported that the actions of VEGF, including the stimulation of angiogenesis, vascular permeability and cell proliferation, are mediated by VEGFR2 [1, 11] through its strong tyrosine kinase activity [11, 12] . The above reports and the present results suggest that VEGF mainly affects bovine endometrial function from the mid to late luteal stages. If the biological action of VEGF is mediated by VEGFR2 in the bovine endometrium, the effect of VEGF in the bovine endometrium should be greatest when VEGFR2 expressions are highest. Unexpectedly, the expressions of VEGF and VEGFR2 reached their highest levels at different stages of the estrous cycle. Further studies are needed to determine precisely the stage of the estrous cycle at which VEGF is more functional in the bovine endometrium. Although the changes of VEGFR2 mRNA and protein expressions were temporally associated, the mRNA and protein expressions of VEGF and VEGFR1 were not coincident. These results may be due to the fact that VEGF and VEGFR1 translation takes more time than the transcription process as reported in cells derived from adenocarcinoma [39] .
We did not study which cell types, epithelial or stromal cells, possess VEGF receptors in the present study. Since VEGF stimulated PGF2α production only by endometrial stromal cells, stromal cells at least seem to express VEGF receptor. Although VEGF did not stimulate PG production by epithelial cells, it is possible that another type of VEGF receptor is expressed in epithelial cells and that VEGF plays other roles in epithelial cell function. Further studies are needed to clarify the localization of VEGFR1 and VEGFR2 in endometrial epithelial and stromal cells.
The concentration of VEGF has been shown to range from 1 to 3 ng/ml and from 3 to 20 ng/g in cyclic bovine oviductal flushings and corpus luteum tissues, respectively [8, 40] . Although the concentrations of VEGF used for treatment of the endometrial epithelial and stromal cells were higher than that of circulating levels (about 1.6 ng/ml) [41] , the local concentration of VEGF in VEGF-producing tissues might be much higher than in plasma. Therefore, the concentration of 200 ng/ml that stimulated PGF2α secretion in the cultured stromal cells may be close to the local concentration of VEGF in the bovine endometrium.
In conclusion, the overall results suggest that VEGF and its receptors are regulated throughout the estrous cycle and that VEGF participates in the local regulation of bovine endometrial function by a selective modulation of PGF2α production in stromal cells in an auto-and/or paracrine manner. 
